3 Results for "

17780-75-5

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "17780-75-5" in MCE Product Catalog:

8
8 Cited Publications
Cat. No.: HY-14197A
CAS No.: 17780-75-5
Purity:  99.92%
Target:  

Monoamine Oxidase

Research Areas:  

Metabolic Disease

Clorgyline hydrochloride is an irreversible and selective inhibitor of monoamine oxidase A (MAO-A) that is used in scientific research, structurally related to Pargyline (HY-A0091A). Clorgyline hydrochloride has little effect on the amounts of conjugated dopamine (DA) present in superfusate of slices from rat striatum. Clorgyline hydrochloride contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups .
loading...
    loading...
Cat. No.: HY-14197AR
CAS No.: 17780-75-5
Research Areas:  

Metabolic Disease

Clorgyline hydrochloride (Standard) is the analytical standard of Clorgyline hydrochloride. This product is intended for research and analytical applications. Clorgyline hydrochloride is an irreversible and selective inhibitor of monoamine oxidase A (MAO-A) that is used in scientific research, structurally related to Pargyline (HY-A0091A). Clorgyline hydrochloride has little effect on the amounts of conjugated dopamine (DA) present in superfusate of slices from rat striatum. Clorgyline hydrochloride contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-14197
CAS No.: 17780-72-2
Purity:  99.76%
Synonyms: M&B 9302
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

Clorgyline (M&B 9302) is an orally active, blood-brain barrier permeable and selective monoamine oxidase A (MAO-A) inhibitor. Clorgyline's selective inhibition of MAO-A leads to reduced metabolism of neurotransmitters such as serotonin (5-hydroxytryptamine), which accumulates in the brain. Clorgyline can be used in the study of depression and neurodegenerative diseases .
loading...
    loading...